A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-0511
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava

Frontiers in Plant Science
Plant Science
2017English

Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients With Solid Malignancies

Clinical Cancer Research
Cancer ResearchOncology
2005English

Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2014English

Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells

Scientific Reports
Multidisciplinary
2016English

Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor With a Heat Shock Protein-90 Inhibitory Profile, in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2008English

The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy